Colecistitis aguda por Kluyvera ascorbata

Batista, Nínive; Díez, Óscar; Moreno, A; Ode, Jesús

doi:10.1016/s0213-005x(02)72819-x

Cited by 8 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only two cases of biliary tract infections due to K. ascorbata have been reported [10,11] (Table 2). One of a 67-year-old woman with acute cholecystitis, and another of a 23-year-old man with liver cirrhosis due to hepatitis B infection.…”

Section: Discussionmentioning

confidence: 99%

The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature

Mutoh

Kobe

Hirano

et al. 2019

IDCases

View full text Add to dashboard Cite

IntroductionKluyvera ascorbata is a gram-negative, catalase-positive, oxidase-negative, aerobic fermentative bacterium with flagella. This organism colonizes in the human body and its pathogenicity is extremely low; few clinical cases of K. ascorbata infection have been reported.Presentation of caseWe report on a patient who experienced severe sepsis and acute cholangitis due to K. ascorbata bacteremia and was treated with levofloxacin following antibiotic susceptibility testing. To our knowledge, this is the first case report of third-generation cephalosporins resistant K. ascorbata infection in Japan.DiscussionAlthough this pathogen produces innate CTX-M type β-lactamases and is generally resistant to first- and second-generation penicillins and cephalosporins, multi-drug resistant K. ascorbata infection, including ceftriaxone resistant infection has seldom been reported.ConclusionThe increase of drug-resistant pathogens is of concern; in such cases, rapid microbial identification and appropriate antibiotic selection are crucial for successful treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature

Mutoh

Kobe

Hirano

et al. 2019

IDCases

View full text Add to dashboard Cite

show abstract

“…In a review of clinically significant Kluyvera infections by Sarria et al 5 in 2001, 21 cases with documented evidence of infection [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] were identified in a review of the literature, and the authors reported 5 new cases. One clinically significant infection reported in the series by Fainstein et al 7 was not included in the review by Sarria et al 5 Since that time, a central venous line infection in a pediatric patient, 22 a case of bacteremia in a patient with Crohn disease, 23 a case of acute cholecystitis, 24 and a nosocomial outbreak of 4 cases of K cryocrescens bacteremia on a cardiovascular ward 25 have been reported, for a total of 34 previously reported cases. The addition of the 7 infections with Kluyvera species in the present report brings the total of clinically significant Kluyvera infections to 41, with 21 of these reported as infections with K ascorbata, 8 as infections with K cryocrescens, and 12 reported as infections with Kluyvera with no species identified.…”

Section: Discussionmentioning

confidence: 99%

Clinically SignificantKluyveraInfections

Carter¹,

Evans²

2005

Am J Clin Pathol

View full text Add to dashboard Cite

To determine the clinical significance of Kluyvera isolates at our institution, we retrospectively analyzed clinical microbiology data from January 1999 to September 2003. We identified 11 isolates classified as Kluyvera ascorbata, 7 of which were considered clinically significant pathogens: 3 cases represented urinary tract infections; 2, bacteremia; 1, a soft tissue infection of the finger; and 1, acute appendicitis with a subsequent intra-abdominal abscess. The age distribution of patients was wide, ranging from 2 months to 73 years. Antimicrobial susceptibility studies of the clinically significant and non-clinically significant Kluyvera isolates showed susceptibility patterns similar to those reported in the medical literature, namely trends of resistance to ampicillin and first- and second-generation cephalosporins. Of the 4 non-clinically significant isolates in our study, 1 was resistant to ciprofloxacin, a finding reported in only 1 other isolate of Kluyvera in the medical literature. Patient outcome after treatment with third-generation cephalosporins and aminoglycosides in the 7 clinically significant cases was good, with no long-term sequelae. The potential virulence of K ascorbata highlights the need for heightened scrutiny of its antimicrobial susceptibility patterns for adequate clinical treatment.

show abstract

“…Kluyvera ascorbata is a Gram-negative microorganism belonging to the family of Enterobacteriaceae and was first identified by Farmer et al [1]. Although it infrequently causes infections, it can cause a wide range of infections including acute appendicitis [2]; biliary tract infection [3]; urinary tract infection [4]; bacteremia with neutropenia and fever [5]; bacteremia and severe sepsis [6]; sepsis accompanied with multiorgan dysfunction [7]; hock and pulmonary hemorrhage [8]; enteritis, central venous catheter infections, and peritonitis [9, 10]; solid organ transplant recipient infection [11]; acute cholecystitis [12]; and cholecystitis and bacteremia [13]. However, no K. ascorbata infections have been reported to date in the oral and maxillofacial region.…”

Section: Introductionmentioning

confidence: 99%

A Case of a Persistent Postoperative Infection Caused by Multidrug-ResistantKluyvera ascorbatain the Oral and Maxillofacial Region

Zou

et al. 2019

Case Reports in Infectious Diseases

View full text Add to dashboard Cite

Introduction. Kluyvera ascorbata infection is rare, but it has been extensively studied because of its potential to cause a wide range of infections and its ability to transfer the gene encoding for CTX-M-type extended spectrum β-lactamases (ESBLs) to other Enterobacteriaceae. Case Presentation. The authors report a case of a 61-year-old Chinese male with a persistent postoperative infection caused by a multidrug-resistant ESBL-producing K. ascorbata. Following antimicrobial susceptibility testing, he was aggressively treated with gentamicin and levofloxacin with a favorable outcome. Conclusion. To our knowledge, this is the first case report of a persistent postoperative infection caused by a multidrug-resistant K. ascorbata in the oral and maxillofacial region. The authors suggest that K. ascorbata infection warrants prompt identification and aggressive antibiotic management, given that ESBL-producing K. ascorbata is resistant to penicillins and first-generation to third-generation cephalosporins.

show abstract

Colecistitis aguda por Kluyvera ascorbata

Cited by 8 publications

References 6 publications

The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature

The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature

Clinically SignificantKluyveraInfections

A Case of a Persistent Postoperative Infection Caused by Multidrug-ResistantKluyvera ascorbatain the Oral and Maxillofacial Region

Contact Info

Product

Resources

About